The New England journal of medicine, 2020-11, Vol.383 (21), p.2030-2040
- Horby, Peter
- Mafham, Marion
- Linsell, Louise
- Bell, Jennifer L
- Staplin, Natalie
- Emberson, Jonathan R
- Wiselka, Martin
- Ustianowski, Andrew
- Elmahi, Einas
- Prudon, Benjamin
- Whitehouse, Tony
- Felton, Timothy
- Williams, John
- Faccenda, Jakki
- Underwood, Jonathan
- Baillie, J Kenneth
- Chappell, Lucy C
- Faust, Saul N
- Jaki, Thomas
- Jeffery, Katie
- Lim, Wei Shen
- Montgomery, Alan
- Rowan, Kathryn
- Tarning, Joel
- Watson, James A
- White, Nicholas J
- Juszczak, Edmund
- Haynes, Richard
- Landray, Martin J
2020
Details
- Autor(en) / Beteiligte
- Horby, Peter
- Mafham, Marion
- Linsell, Louise
- Bell, Jennifer L
- Staplin, Natalie
- Emberson, Jonathan R
- Wiselka, Martin
- Ustianowski, Andrew
- Elmahi, Einas
- Prudon, Benjamin
- Whitehouse, Tony
- Felton, Timothy
- Williams, John
- Faccenda, Jakki
- Underwood, Jonathan
- Baillie, J Kenneth
- Chappell, Lucy C
- Faust, Saul N
- Jaki, Thomas
- Jeffery, Katie
- Lim, Wei Shen
- Montgomery, Alan
- Rowan, Kathryn
- Tarning, Joel
- Watson, James A
- White, Nicholas J
- Juszczak, Edmund
- Haynes, Richard
- Landray, Martin J
- Titel
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- Ist Teil von
- The New England journal of medicine, 2020-11, Vol.383 (21), p.2030-2040
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- Among 4716 hospitalized adult patients with Covid-19 in the United Kingdom, those who were treated with hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2022926Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7556338
- Format
- –
- Schlagworte
- Aged, Aged, 80 and over, Antiviral Agents - adverse effects, Antiviral Agents - therapeutic use, Arrhythmia, Betacoronavirus, Chloroquine, Clinical trials, Coronavirus Infections - drug therapy, Coronavirus Infections - mortality, Coronaviruses, COVID-19, COVID-19 Drug Treatment, Death, Fatalities, Female, Heart, Hospitalization, Humans, Hydroxychloroquine, Hydroxychloroquine - adverse effects, Hydroxychloroquine - therapeutic use, Male, Middle Aged, Mortality, Original, Pandemics, Pneumonia, Viral - drug therapy, Pneumonia, Viral - mortality, Respiration, Artificial, SARS-CoV-2, Treatment Failure, Ventilation